Top Page
Menicon Co
(Frankfurt:7780)
Menicon Co (7780) vs. iShares MSCI Japan ETF (EWJ)
Menicon Co Business Overview & Revenue Model
Menicon Co Financial Statement Overview
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 120.30B | 121.49B | 116.19B | 110.19B | 100.17B | 86.21B |
| Gross Profit | 64.61B | 65.08B | 61.01B | 58.48B | 52.88B | 45.82B |
| EBITDA | 17.77B | 18.52B | 15.74B | 19.51B | 17.25B | 14.13B |
| Net Income | 5.08B | 5.62B | 4.54B | 7.38B | 6.48B | 5.95B |
Balance Sheet | ||||||
| Total Assets | 210.87B | 187.28B | 179.81B | 152.52B | 130.98B | 126.73B |
| Cash, Cash Equivalents and Short-Term Investments | 63.76B | 42.05B | 46.91B | 41.28B | 33.05B | 41.45B |
| Total Debt | 98.15B | 75.09B | 70.79B | 53.58B | 42.44B | 45.30B |
| Total Liabilities | 122.86B | 101.12B | 98.01B | 77.86B | 63.94B | 65.75B |
| Stockholders Equity | 87.96B | 86.10B | 81.75B | 74.61B | 66.99B | 60.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -77.00M | -9.47B | -226.00M | -3.23B | -1.25B |
| Operating Cash Flow | 0.00 | 13.94B | 11.87B | 12.75B | 12.72B | 10.63B |
| Investing Cash Flow | 0.00 | -19.66B | -21.57B | -13.78B | -16.15B | -15.63B |
| Financing Cash Flow | 0.00 | 714.00M | 14.55B | 8.90B | -5.40B | 28.91B |
Menicon Co Technical Analysis
Menicon Co Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | €86.10B | 15.29 | 6.62% | 2.47% | 4.56% | 24.10% | |
51 Neutral | $7.50B | 0.32 | -61.87% | 2.27% | 17.10% | 1.59% | |
| $1.32B | 23.32 | 26.63% | 1.48% | ― | ― | ||
75 Outperform | ¥55.99B | 13.82 | 1.90% | 17.45% | 43.39% | ||
66 Neutral | ¥14.41B | 13.19 | 3.15% | 2.58% | -53.08% | ||
62 Neutral | ¥19.44B | 14.40 | 2.17% | 14.12% | 56.92% | ||
61 Neutral | ¥70.51B | 16.26 | 3.14% | 15.55% | 42.14% |
Menicon Co Corporate Events
Menicon Co., Ltd. announced an interim report on its share buyback program, which was resolved at a board meeting on June 19, 2025. The company has bought back 284,900 common shares for JPY 305,168,900 between June 20 and June 30, 2025, as part of a broader plan to repurchase up to 2.3 million shares by December 20, 2025. This move is aimed at enhancing shareholder value and optimizing capital structure.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. announced the issuance of share remuneration-type stock options to directors and employees of its subsidiaries, aiming to enhance motivation and contribute to the sustained improvement of the company’s business performance. This strategic move is expected to promote management efforts to increase corporate value, potentially impacting the company’s operational dynamics and stakeholder interests.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. has announced the issuance of share remuneration-type stock options to directors of its subsidiaries in Japan. This move is aimed at enhancing motivation and aligning the interests of directors with the company’s long-term goals, thereby promoting sustained improvement in business performance and corporate value.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. announced the issuance of share remuneration-type stock options to its executive officers, directors, and employees to enhance motivation and contribute to the company’s sustained business performance and corporate value. This strategic move aims to align the interests of key personnel with the company’s long-term goals, potentially impacting its operational efficiency and market positioning positively.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. has announced a share buyback program, resolving to repurchase up to 2.3 million shares, which is 3% of its total issued shares, at a maximum cost of JPY 2.4 billion. This decision is part of a broader strategy to enhance shareholder value while addressing the current stock price, which the company believes does not reflect its future profitability. The buyback will be funded from cash on hand and is aligned with Menicon’s medium-term management plan, which includes expanding production capacity to meet the growing demand for daily disposable contact lenses. The company’s new plant in Malaysia is expected to significantly boost supply capacity by March 2026, contributing to economies of scale and improved business performance.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. has announced that it will receive a dividend of JPY 3,000 million from its consolidated subsidiary. This dividend will be recorded as extraordinary income in the non-consolidated financial results for the fiscal year ending March 31, 2026, but it will not affect the consolidated financial results for the same period.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. has updated its Medium-Term Management Plan, maintaining its overall sales targets but revising specific sales goals for its ‘1-DAY lens’ and orthokeratology-related strategies. The company anticipates strong global demand for its ‘1-DAY lens’ products and plans to increase production capacity with a new plant in Malaysia, aiming to enhance profitability and expand sales internationally. However, growth in the orthokeratology market is expected to slow in China due to economic factors and emerging technologies, prompting Menicon to focus on other Asian markets for growth.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a 4.6% increase in net sales to ¥121,491 million and a significant rise in profit attributable to owners of the parent by 23.8% to ¥5,621 million. The company also announced changes in its scope of consolidation, including the inclusion of three new subsidiaries and the exclusion of one, which may impact its market positioning and operational strategy.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. announced the recording of extraordinary income due to the gain on reversal of share acquisition rights, stemming from the redemption of ¥23 billion Zero Coupon Convertible Bonds. This financial maneuver is reflected in the company’s consolidated financial results for the fiscal year ending March 31, 2025, potentially impacting its financial standing and stakeholder interests.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. has announced the agenda for its 68th Annual General Meeting of Shareholders, scheduled for June 26, 2025. Key proposals include the election of eight directors and the granting of stock options to subsidiaries’ directors and employees, both domestic and non-resident. This move aims to enhance corporate value and incentivize management to improve business performance.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen2300.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
Menicon Co., Ltd. announced it will record extraordinary losses due to structural reforms, including impairment losses on lens care product manufacturing equipment and expenses related to withdrawing from certain healthcare businesses. These actions are part of a strategic review to improve capital efficiency and focus on growth areas, such as orthokeratology and global expansion. Additionally, the company is restructuring its European operations to enhance efficiency and profitability, despite incurring temporary costs. Menicon has also revised its dividend policy to ensure stability, reflecting its commitment to long-term shareholder value.